Healthcare Faces Congressional Oversight Heading Into 2026 Midterms and Beyond

Congressional Investigations attorneys Ashley Chavous and Christopher Armstrong co-authored a Healthcare Dive article discussing how a potential shift in congressional control following the 2026 midterm elections could expand oversight of the healthcare industry. Their article examines the areas likely to draw increased scrutiny from congressional Democrats, including healthcare affordability, prescription drug pricing, private equity ownership, hospital consolidation, artificial intelligence and healthcare data practices. The authors also explore potential investigations involving the Trump Administration, such as federal contracting, regulatory decision-making, negotiations with federal agencies and relationships between industry stakeholders and political appointees, and outline steps healthcare organizations can take to assess risk, strengthen compliance measures and prepare for potential congressional inquiries.

READ: Healthcare Faces Congressional Oversight Heading Into 2026 Midterms and Beyond